1. Home
  2. India
  3. LTC scam: CBI seeks papers from Rajya Sabha secretariat

LTC scam: CBI seeks papers from Rajya Sabha secretariat

November 4, 2013

LTC_scamNew Delhi, Nov 4: The CBI on Monday approached the Rajya Sabha secretariat seeking documents related to fake travel bills allegedly submitted by a JD(U) MP against whom a case has been registered for making such claims.

CBI sources said a team has again gone to the secretariat to collect these documents.

The agency has registered its first FIR in the Leave Travel Concession(LTC) scam against JD(U) Rajya Sabha MP Anil Kumar Sahani for allegedly siphoning off around Rs. 9.5 lakh by presenting fake air tickets and boarding passes.

Besides Sahani, Air India customer Service agent Rubaina Akhtar and Lajpat Nagar-based travel operator Air Cruise Travels Private Ltd have also been named in the FIR in the scam in which LTC claims were forged for travel on state-run Air India.

In his defence, Mr. Sahani had refuted the allegation claiming that it was he who had complained to the authorities about 20 fake tickets being submitted in his name.

He has alleged that it was his personal assistant who had submitted these tickets for claims but no money was ever transferred to his account.

The MP has claimed that he had brought this matter to the notice of concerned authorities and even submitted that complaint letter to CBI when it searched his premises here.

The tour operator and Air India did not offer any comments.

CBI has alleged that Mr. Sahani made false claims of approximately Rs. 9.5 lakh for seven business class return air tickets costing nearly Rs. 1.34 lakh each to Port Blair in December 2012 using fake air tickets and boarding passes for himself and six associates, the sources said.

CBI sources said the agency has registered a case of cheating and forgery among other charges under Indian Penal Code (IPC) and relevant provisions of the Prevention of Corruption Act.

CBI has alleged that the MP purchased seven return e-tickets in connivance with the tour operator and the Air India employee. He also allegedly used online service to get boarding passes using web check-in basis.

The sources said just before the boarding time, these boarding passes and tickets were allegedly cancelled using the sign-in code of Akhtar, the Air India customer service agent, and money was refunded with little deduction.

Meanwhile, the e-tickets and boarding passes which were earlier issued were allegedly presented to claim the travel expenses by the MP.

The sources said even though no expenses were incurred by the MP, he allegedly claimed the amount using these e-tickets and boarding passes which were cancelled.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 19,2020

New Delhi, Jul 19: With the highest single-day spike of 38,902 cases reported in the last 24 hours, India's total COVID-19 tally on Sunday reached 10,77,618, informed the Union Health and Family Welfare Ministry on Sunday.

The death toll has gone up to 26,816 with 543 fatalities reported in the last 24 hours.

The Health Ministry said the total number of cases includes 3,73,379 active cases and 6,77,423 patients have been cured/discharged/migrated.

Maharashtra remains the worst affected state with 3,00,937 cases reported until Saturday.
Meanwhile, as per the information provided by the Indian Council of Medical Research (ICMR), 1,34,33,742 samples have been tested for COVID-19 till July 18, of these 3,61,024 samples were tested yesterday.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
April 14,2020

New Delhi, Apr 14: Prime Minister Narendra Modi has announced the extension of a nationwide lockdown till May 3 to contain the spread of Covid-19 as the number of novel coronavirus cases surged past 10,000-mark on Tuesday. Hinting at partial relief, however, the Prime Minister said there could be some relaxations after April 20 in places where there is no hotspot.

Lockdown 2.0 will come into force from April 14 till May 3, PM Modi said in a televised address to the nation on Tuesday. The 19-day extension of the lockdown till May 3 is an attempt to contain the spread of novel coronavirus which has affected over 10,000 people in India. 

Even before #COVID19 cases touched 100, India made it compulsory for foreign returnees to remain in 14 days isolation. We imposed 21-day lockdown when we had 550 cases: PM Narendra Modi https://t.co/qi8MgG8qPQ

— ANI (@ANI) April 14, 2020
PM Modi said the Centre will closely monitor hotspots in states across India and added that those areas where there are no hotspots will get partial relief. “Till April 20, all districts, localities, states will be closely monitored, as to how strictly they are implementing norms. States where hotspots are contained could be allowed to resume some important activities, but with certain conditions,” the PM said.

The Prime Minister, in his address to India on Tuesday, began by lauding the efforts of Indians in the fight against novel coronavirus. “Covid-19 is spreading fast but India’s fight against coronavirus is going strong. It is because of your efforts that we are able to put up a fight,” the PM said as he thanked people for their co-operation.

PM Modi said, “People have gone through hardships to save India. I know how many difficulties you faced. I respectfully bow to the people of India for their sacrifice.”

The national lockdown first came into force from March 25 when the PM took an unprecedented measure in the fight against Covid-19. The lockdown was scheduled to end today.

STATES PUSHED FOR LOCKDOWN 2.0

The decision to extend the lockdown followed after a broad consensus emerged that the national lockdown should be extended by at least two weeks following a meeting between PM Modi and state chief ministers on Saturday.

It was reportedly after this meet with the Prime Minister that it was decided that the nationwide lockdown will be extended to tackle the spread of Coivid-19. The extension request from states came despite concerns that the shutdown will put millions out of work.

PM has taken correct decision to extend lockdown. Today, India’s position is better than many developed countries because we started lockdown early. If it is stopped now, all gains would be lost. To consolidate, it is imp to extend it

— Arvind Kejriwal (@ArvindKejriwal) April 11, 2020
"If it is stopped now, all gains would be lost. To consolidate, it is imp (important) to extend it," Arvind Kejriwal had written on Twitter after the meeting while he added that PM Modi had "taken (a) correct decision to extend (the) lockdown”.

Several states had, however, pushed for resumption of some economic activities like in the farming sector in areas where no cases of the novel coronavirus have been reported.

ALL THAT HAS HAPPENED TILL NOW

Prime Minister Narendra Modi first addressed an anxious nation on March 19 as the coronavirus pandemic emerged as a serious concern for the country. In his televised address, the PM asked the people to observe ‘Janata Curfew’ for March 22.
The Prime Minister urged Indians to remain indoors as much as possible as he suggested ways to battle the coronavirus pandemic.

On March 24, the Prime Minister came back and announced a 21-day lockdown across the country. In his second address, PM Modi said the step was taken as it was the only way to break the chain of infection. The lockdown was to be in effect till April 14.

PM Modi later asked citizens to make noise at 5 pm to show their appreciation for medics, nurses and sanitation workers. This call was well received as Indians came out to clap, clang metal vessels and ring bells to cheer workers battling the spread of the coronavirus.

Ten days into the lockdown, the Prime Minister addressed the nation again and asked people to light candles, lamps and hold mobile phone torches for nine minutes from 9 pm on April 5 to demonstrate a collective will to fight coronavirus.

As of Tuesday morning, the death toll due to coronavirus has climbed to 339 with over 50 deaths within 24 hours. The number of cases in the country, meanwhile, had crossed the 10,000-mark, according to the Union Health Ministry. Over a thousand have been cured and discharged.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.